Cheryl Mensah, MD
Assistant Professor of Medicine (Medical Oncology & Hematology)Cards
About
Research
Publications
2024
Real-world experience with iron chelation therapy in transfusion-dependent thalassemia: impact of the oral chelators' era.
Pines M, Kleinert D, Thomas C, Mensah C, Musallam KM, Sheth S. Real-world experience with iron chelation therapy in transfusion-dependent thalassemia: impact of the oral chelators' era. Ann Hematol 2024, 103: 5229-5234. PMID: 39672943, DOI: 10.1007/s00277-024-06092-1.Peer-Reviewed Original Research
2021
Prevalence of hypercoagulable states in stented thrombotic iliac vein compression syndrome with comparison of re-intervention and anticoagulation regimens
Cramer P, Mensah C, DeSancho M, Malhotra A, Winokur R, Kesselman A. Prevalence of hypercoagulable states in stented thrombotic iliac vein compression syndrome with comparison of re-intervention and anticoagulation regimens. World Journal Of Radiology 2021, 13: 371-379. PMID: 35070117, PMCID: PMC8716936, DOI: 10.4329/wjr.v13.i12.371.Peer-Reviewed Original ResearchIliac vein compression syndromeRe-intervention rateRe-interventionNegative patientsCompression syndromeStent patencyThrombophilia testingDual therapyPrevalence of hypercoagulable statesPresence of thrombophiliaOutcomes of patientsIliac vein compressionHalf of patientsRetrospective observational analysisWilcoxon rank sum testNon-thrombotic lesionsRank sum testChi-square testIliocaval thrombosisTriple therapyPost-procedural managementVenous stentingThrombophilia patientsIliac veinNo significant difference
Clinical Care
Overview
Cheryl Mensah, MD, specializes in hematology, focusing on the treatment of hemoglobinopathies (inherited, generic blood disorders), such as thalassemia, as well as a range of anemias and other hematologic conditions.
“My favorite part of my job is witnessing an intervention I’ve performed significantly improve a patient’s symptoms and quality of life,” she says. “These moments make my work profoundly rewarding.”
Equally important to Dr. Mensah is easing the anxiety that patients often feel when visiting a doctor’s office. “I encourage my patients to prepare before their visit, ask questions, and provide any relevant information in advance so that I can address their concerns more comprehensively,” she says.
“Additionally, I reassure them that they are always welcome to ask further questions even after the appointment, to ensure they feel fully supported,” she adds. “Many patients are anxious before the visit, however, the goal of the visit is to help them with either a diagnosis, treatment, or to rule out aggressive hematologic conditions. They should come prepared with questions and feel empowered to engage in their health care.”
An assistant professor of medicine at Yale School of Medicine, Dr. Mensah is the inaugural medical director of the Thalassemia Program at the Yale Cancer Center. Her research aims to enhance understanding and treatment of hemoglobin disorders. As both a clinician and researcher, her passion is working on red blood cell disorders. It’s a passion she developed by working with her first mentor, Dr. Anthony Shields, a hematologist-oncologist.
“My career goal is working with with patients with hemoglobin disorders and participating in research that advances the field,” she says.
Dr. Mensah completed her medical training at Wayne State University and her residency and fellowship training in hematology-oncology at Northwell Health.
Clinical Specialties
News
Get In Touch
Contacts
Yale Cancer Center
77 Lafayette Pl
Greenwich, CT 06830
United States
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.